Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 225 recruiting now early-phase tilt #2 of 28,707 conditions

Healthy: early-phase trial registry

225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2 of 28,707 conditions by registered trial count.

1,096 US clinical trials · 225 currently recruiting · #2 of 28,707 conditions by registered trial count

Healthy: 1,096 US clinical trials tracked, 225 recruiting.

Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.

Enrollment posture brief

Registry condition healthy

OPEN 225 | RECR 21% | LATE 43 | EARLY 546 | RANK #2 | SPON 55

Nearest open-share peer: Psoriasis (20% recruiting · 127 trials)

Prostate Cancer36.7%Depression35.7%Breast Cancer33.8%Obesity28.9%Healthy (this)21%
Open-enrollment share among volume-matched conditions near Healthy

Healthy lists 225 open slots (21% of 1,096 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Healthy is recruiting below its size-band peers.

    225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Healthy trials is spread across many organizations.

    Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.

  3. Most Healthy trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.

  4. Healthy research is mostly interventional.

    905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 1518Phase 228Phase 311Phase 432

Open and recent trials

1,096 total, page 6 of 22

ACTIVE NOT RECRUITING 80 participants

Blood Vessel Anatomy and Blood Flow Regulation

University of Wisconsin, Madison

NCT05396287

ACTIVE NOT RECRUITING Phase 1 72 participants

A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004)

Merck Sharp & Dohme

NCT06688058

ACTIVE NOT RECRUITING Phase 1 72 participants

Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).

Merck Sharp & Dohme

NCT06623409

ACTIVE NOT RECRUITING Phase 1 71 participants

A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults

Pfizer

NCT06686797

ACTIVE NOT RECRUITING 66 participants

Registry for Mayo Clinic Adult Congenital Heart Disease Control Population

Mayo Clinic

NCT05773300

ACTIVE NOT RECRUITING NA 66 participants

Racial/Ethnic in Calcium and Sodium Metabolism

San Diego State University

NCT05537857

ACTIVE NOT RECRUITING Phase 1 62 participants

A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)

Merck Sharp & Dohme

NCT07305831

ACTIVE NOT RECRUITING NA 60 participants

Vitamin and Mineral Absorption From Milk and PBMAs

Clinical Nutrition Research Center, Illinois Institute of Technology

NCT05898217

ACTIVE NOT RECRUITING Phase 1 60 participants

A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

Merck Sharp & Dohme

NCT07300280

ACTIVE NOT RECRUITING NA 60 participants

Resistance Training With Blood Flow Restriction

University of Oklahoma

NCT05863039

ACTIVE NOT RECRUITING Phase 1 59 participants

A Study of SPY003-207 in Healthy Volunteers

Spyre Therapeutics

NCT06873724

ACTIVE NOT RECRUITING NA 56 participants

A Study of Adipose Tissue in Adaptive Responses to Exercise

Mayo Clinic

NCT06053125

ACTIVE NOT RECRUITING NA 55 participants

American Cranberries to Prevent UTIs in Susceptible Women

University of Florida

NCT04626362

ACTIVE NOT RECRUITING NA 48 participants

The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions

University of Pennsylvania

NCT04225442

ACTIVE NOT RECRUITING Early Phase 1 46 participants

Study to Assess the Safety, Tolerability, PK and PD of ABX1100

Aro Biotherapeutics

NCT06109948

ACTIVE NOT RECRUITING NA 44 participants

Olive Oil Polyphenols and Cardiovascular Health Biomarkers

University of California, Davis

NCT04149288

ACTIVE NOT RECRUITING NA 44 participants

Methylation Diet and Lifestyle Study

National University of Natural Medicine

NCT03472820

ACTIVE NOT RECRUITING NA 40 participants

Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers

Carsten Skarke, MD

NCT00682318

ACTIVE NOT RECRUITING 40 participants

Clinical Validation of the Norbert Health Device for Pulse Rate Measurement at Vigilant Clinical Testing

Norbert Health

NCT06917352

ACTIVE NOT RECRUITING NA 40 participants

A Study of Hydrogen Peroxide-Generating E-bandage Safety

Mayo Clinic

NCT05940207

ACTIVE NOT RECRUITING NA 40 participants

MOS Prebiotic Potential in Older Adults

University of Florida

NCT05939336

ACTIVE NOT RECRUITING NA 40 participants

Effects of Vibration on Motor Function of Survivors of Chronic Stroke

Shirley Ryan AbilityLab

NCT06663501

ACTIVE NOT RECRUITING NA 40 participants

Effects of a Mushroom Blend on Gastrointestinal Symptoms and the Microbiome

University of South Carolina

NCT07027462

ACTIVE NOT RECRUITING Phase 1 36 participants

Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in Obesity

Vanderbilt University Medical Center

NCT03318094

ACTIVE NOT RECRUITING NA 34 participants

Clinical Study to Assess the Effects of Prebiotic and Probiotic Supplement

Olly, PBC

NCT06794619

ACTIVE NOT RECRUITING Phase 1 32 participants

A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults

Lohocla Research Corporation

NCT06633562

ACTIVE NOT RECRUITING Phase 1 32 participants

A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment

Eli Lilly and Company

NCT07165015

ACTIVE NOT RECRUITING Phase 1 30 participants

A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

Merck Sharp & Dohme

NCT07266818

ACTIVE NOT RECRUITING 30 participants

Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A

University of Pennsylvania

NCT02095288

ACTIVE NOT RECRUITING Phase 4 30 participants

Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion

Mayo Clinic

NCT05264727

ACTIVE NOT RECRUITING 30 participants

High-field Brain Magnetic Resonance Spectroscopy

University of Minnesota

NCT02053701

ACTIVE NOT RECRUITING NA 30 participants

Effects of CBD on 2 Mile Run Time Trial Performance

University of Northern Colorado

NCT06364254

ACTIVE NOT RECRUITING NA 30 participants

Spectral Characteristics of Memory Transformation

Medical University of South Carolina

NCT05946616

ACTIVE NOT RECRUITING Phase 1 30 participants

Xanthohumol Metabolism and Signature

National University of Natural Medicine

NCT03735420

ACTIVE NOT RECRUITING Phase 1 29 participants

Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT

University of Pennsylvania

NCT02379338

ACTIVE NOT RECRUITING 28 participants

Sallie Life U Feasibility Study

Life University

NCT06812897

ACTIVE NOT RECRUITING 24 participants

Lipids and Energy Study: Optimizing the Analysis of Lipids and Energy Metabolism in Blood Samples

Ohio State University

NCT04981288

ACTIVE NOT RECRUITING Phase 4 24 participants

Pharmacokinetics of Transdermal Metronidazole

University of Iowa

NCT05929794

ACTIVE NOT RECRUITING Phase 1 24 participants

A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954

Visterra

NCT06937593

ACTIVE NOT RECRUITING 20 participants

Air Pollution, Asthma and Circadian Clocks

University of Pennsylvania

NCT03406351

ACTIVE NOT RECRUITING Phase 1 20 participants

Comparing the Effects of Psilocin and Psilocybin in Healthy Adults

University of California, San Francisco

NCT05317689

ACTIVE NOT RECRUITING NA 20 participants

Time and Nutrient-Dependent Effects of Aerobic Exercise on Metabolism in Adults (TANDEM Study)

University of Colorado, Denver

NCT06311487

ACTIVE NOT RECRUITING NA 20 participants

Characterizing the Scalp Tolerability of TMS

Florida State University

NCT06354686

ACTIVE NOT RECRUITING Phase 1 18 participants

Target Engagement of Terazosin in Healthy Adults

University of Iowa

NCT04551040

ACTIVE NOT RECRUITING Phase 1 18 participants

Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects

Corcept Therapeutics

NCT07240116

ACTIVE NOT RECRUITING Phase 1 16 participants

A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)

Merck Sharp & Dohme

NCT07334860

ACTIVE NOT RECRUITING NA 15 participants

Renal Metabolism of Glycolate to Oxalate

University of Alabama at Birmingham

NCT04437225

ACTIVE NOT RECRUITING Phase 2 15 participants

Effectiveness of Aquamin® in Mitigating Halitosis

University of Michigan

NCT05058638

ACTIVE NOT RECRUITING NA 14 participants

Optimizing Phototesting and Investigating Photobiology of Visible Light

Henry Ford Health System

NCT05964907

ACTIVE NOT RECRUITING 13 participants

Effects of Maternal Obesity on Offspring Brain Development

Arkansas Children's Hospital Research Institute

NCT03499587

← Previous Page 6 of 22 Next →

Phase Distribution

PhaseTrial count
Phase 1 518
Phase 2 28
Phase 3 11
Phase 4 32

Named interventions

Most-linked intervention names on Healthy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
100 trials
Placebo Other
32 trials
Placebo Dietary supplement
15 trials
Moxifloxacin Drug
9 trials
Midazolam Drug
9 trials
placebo Drug
8 trials
Placebo Biological
7 trials
Omeprazole Drug
6 trials

US sites by state

Facility locations filed on Healthy trials. A trial with sites in several states counts in each.

California 149 trials
Florida 118 trials
Maryland 114 trials
Texas 111 trials
Minnesota 73 trials
Massachusetts 52 trials
Connecticut 49 trials
Pennsylvania 46 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Healthy page

1,096 registered trials, 225 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Healthy condition card totals 1,096 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.